Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98250102 | 9825010 | 2 | F | 20140107 | 20140117 | 20160831 | EXP | US-JNJFOC-20140107646 | JANSSEN | MOWRY JB, SPYKER DA, CANTILENA LR, BAILEY J, FORD M. 2012 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 30TH ANNUAL REPORT. CLINICAL TOXICOLOGY 2013;51:949-1229. | 86.00 | YR | E | F | Y | 0.00000 | 20160831 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98250102 | 9825010 | 1 | PS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | N | 19872 | UNSPECIFIED | |||||||||
| 98250102 | 9825010 | 2 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | N | 19872 | UNSPECIFIED | |||||||||
| 98250102 | 9825010 | 3 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | N | 20505 | UNSPECIFIED | |||||||||
| 98250102 | 9825010 | 4 | SS | BUPROPION. | BUPROPION | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 98250102 | 9825010 | 5 | SS | DORZOLAMIDE/TIMOLOL | DORZOLAMIDETIMOLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 98250102 | 9825010 | 6 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 98250102 | 9825010 | 7 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 98250102 | 9825010 | 8 | SS | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98250102 | 9825010 | 2 | Product used for unknown indication |
| 98250102 | 9825010 | 3 | Product used for unknown indication |
| 98250102 | 9825010 | 4 | Product used for unknown indication |
| 98250102 | 9825010 | 5 | Product used for unknown indication |
| 98250102 | 9825010 | 6 | Product used for unknown indication |
| 98250102 | 9825010 | 7 | Product used for unknown indication |
| 98250102 | 9825010 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98250102 | 9825010 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98250102 | 9825010 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |